niflumic acid [Ligand Id: 2439] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL63323 (Niflugel, Niflumic acid, NSC-758196, UP 83, UP-83)
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
  • dihydroorotate dehydrogenase (quinone)/Dihydroorotate dehydrogenase in Human [ChEMBL: CHEMBL1966] [GtoPdb: 2604] [UniProtKB: Q02127]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
  • KNa1.2 in Human [GtoPdb: 386] [UniProtKB: Q6UVM3]
There should be some charts here, you may need to enable JavaScript!
  • TRPA1 in Rat [GtoPdb: 485] [UniProtKB: Q6RI86]
There should be some charts here, you may need to enable JavaScript!
  • ClC-Ka in Human [GtoPdb: 700] [UniProtKB: P51800]
There should be some charts here, you may need to enable JavaScript!
  • ClC-Kb in Human [GtoPdb: 701] [UniProtKB: P51801]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219]
ChEMBL DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) B 5.97 pIC50 1064 nM IC50 DrugMatrix in vitro pharmacology data
COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354]
ChEMBL DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) B 6.04 pIC50 918 nM IC50 DrugMatrix in vitro pharmacology data
dihydroorotate dehydrogenase (quinone)/Dihydroorotate dehydrogenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1966] [GtoPdb: 2604] [UniProtKB: Q02127]
ChEMBL Inhibition of human recombinant DHODH B 4.77 pIC50 17000 nM IC50 ACS Med Chem Lett (2016) 7: 1112-1117 [PMID:27994748]
GPR35/G-protein coupled receptor 35 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293267] [GtoPdb: 102] [UniProtKB: Q9HC97]
ChEMBL Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis B 5.44 pKi 3610 nM Ki J. Med. Chem. (2013) 56: 7084-7099 [PMID:23888932]
ChEMBL Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins B 5.89 pIC50 1280 nM IC50 ACS Med. Chem. Lett. (2012) 3: 165-169 [PMID:24900447]
ChEMBL Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay F 4.4 pEC50 40200 nM EC50 ACS Med. Chem. Lett. (2012) 3: 165-169 [PMID:24900447]
ChEMBL Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay B 4.51 pEC50 30800 nM EC50 J. Med. Chem. (2013) 56: 7084-7099 [PMID:23888932]
ChEMBL Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay B 4.82 pEC50 15000 nM EC50 J. Med. Chem. (2013) 56: 7084-7099 [PMID:23888932]
ChEMBL Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay F 5.94 pEC50 1150 nM EC50 ACS Med. Chem. Lett. (2012) 3: 165-169 [PMID:24900447]
ChEMBL Agonist activity at human GPR35 by DMR assay B 5.95 pEC50 1110 nM EC50 J. Med. Chem. (2013) 56: 7084-7099 [PMID:23888932]
Transcriptional enhancer factor TEF-3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295828] [UniProtKB: Q15561]
ChEMBL Binding affinity to human His-tagged TEAD4 YBD (217 to 434 residues) expressed in Escherichia coli BL21(DE3) after 30 mins by ITC assay B 4.55 pKd 28000 nM Kd J Med Chem (2018) 61: 5057-5072 [PMID:29251924]
ChEMBL Binding affinity to N-terminal His6-tagged human TEAD4 YAP binding domain (217 to 434 residues) expressed in Escherichia coli C43 (DE3) cells by ITC method B 4.55 pKd 28000 nM Kd J Med Chem (2020) 63: 11972-11989 [PMID:32907324]
ChEMBL Inhibition of CPM binding to N-terminal His6-tagged human TEAD4 (217 to 434 residues) expressed in Escherichia coli BL21-CodonPlus (DE3)-RIPL cells preincubated for 10 mins followed by CPM addition and measured after 1 hr by fluorescence assay B 4.38 pIC50 41900 nM IC50 J Med Chem (2020) 63: 11972-11989 [PMID:32907324]
ChEMBL Inhibition of FITC-labeled palmitate tracer binding to N-terminal His6-tagged human TEAD4 (217 to 434 residues) expressed in Escherichia coli BL21-CodonPlus (DE3)-RIPL cells preincubated for 10 mins followed by FITC-labeled palmitate tracer addition and measured after 1 hr by fluorescence assay B 5.23 pIC50 5900 nM IC50 J Med Chem (2020) 63: 11972-11989 [PMID:32907324]
Transcription factor SOX-18 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523228] [UniProtKB: P43680]
ChEMBL Inhibition of mouse SOX18 expressed in African green monkey COS7 cells assessed as reduction in SOX18 transcriptional activity by luciferase reporter gene assay B 4.3 pIC50 50500 nM IC50 WO-2018112545-A1. Inhibitors of sox18 protein activity for treating angiogenesis- and/or lymphangiogenesis-related diseases (null)
transthyretin/Transthyretin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766]
ChEMBL Binding affinity to TTR (unknown origin) by isothermal titration calorimetric analysis B 6.59 pKd 260 nM Kd J. Med. Chem. (2015) 58: 6507-6515 [PMID:26214366]
ChEMBL FP Assay: The FP assay was then adapted for HTS and used to screen ~120,000 small molecule library for compounds that displaced probe 5 from the T4 binding of TTR. The FP assay was performed in 384-well plate using very low concentration of probe 5 (1.5 nM) and TTR (50 nM) in a 10 μL assay volume. A detergent (0.01% Triton-X100) was added to the assay buffer to avoid any false positive hits from promiscuous, aggregate-based inhibitors. The assay demonstrated robust performance, with a very good dynamic range (−70-230 mP) and a Z′ factor in the range of 0.57-0.78 (FIGS. 4A and 4B). "Hits" were defined as compounds that resulted in at least 50% decrease in fluorescence polarization and demonstrated relative fluorescence between 70 and 130%. Many fluorescence quenchers and enhancers having less than 70% and greater than 130% total fluorescence relative to a control, respectively, were excluded from the hit list. 200 compounds were designated as positive hits (0.167% hit rate). B 6.54 pIC50 289 nM IC50 US-8877795-B2. Identification of stabilizers of multimeric proteins (2014)
KNa1.2 in Human [GtoPdb: 386] [UniProtKB: Q6UVM3]
GtoPdb - - 8.68 pEC50 2.1 nM EC50 J Gen Physiol (2010) 135: 275-95 [PMID:20176855];
Mol Pharmacol (2012) 82: 795-802 [PMID:22851714]
TRPA1 in Rat [GtoPdb: 485] [UniProtKB: Q6RI86]
GtoPdb Two electrode voltage clamp - 3.3 pEC50 - - - Pflugers Arch (2010) 459: 579-92 [PMID:19888597]
ClC-Ka in Human [GtoPdb: 700] [UniProtKB: P51800]
GtoPdb - - 5 pEC50 10000 nM EC50
ClC-Kb in Human [GtoPdb: 701] [UniProtKB: P51801]
GtoPdb - - 5 pEC50 10000 nM EC50

ChEMBL data shown on this page come from version 28:

Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, Cibrián-Uhalte E, Davies M, Dedman N, Karlsson A, Magariños MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]